TickerFactsScreenerDevelopers

Monopar Therapeutics (MNPR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $2.07M2017: $8.98M2018: $6.89M2019: $13.21M2020: $16.74M2021: $20.30M2022: $8.19M2023: $7.27M2024: $45.82M2025: $61.83M$61.83M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$61.83M+35.0%
2024$45.82M+530.6%
2023$7.27M-11.2%
2022$8.19M-59.7%
2021$20.30M+21.3%
2020$16.74M+26.7%
2019$13.21M+91.7%
2018$6.89M-23.3%
2017$8.98M+333.4%
2016$2.07M—